Stock Track | GENOR-B Soars 5.23% Intraday as Merger Completion and Renaming Take Effect

Stock Track2025-12-30

GENOR-B (06998) surged 5.23% during the intraday session on Tuesday, reflecting strong investor optimism following the completion of its proposed merger and corporate renaming.

The company announced that all conditions for the merger have been fulfilled, with the completion taking effect at 9:00 a.m. (Hong Kong Time) on December 30, 2025. Concurrently, the company's name has been changed from "Genor Biopharma Holdings Limited" to "Edding Genor Group Holdings Limited," signaling a new phase in its corporate identity.

Additionally, the company has appointed new directors, including Mr. Ni Xin and Ms. Zhai Jing as executive directors, and Dr. David Guowei Wang as a non-executive director, among others. These changes are expected to bring fresh leadership and strategic direction to the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159197708?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159197708","market":"us","top_or_hot":-1,"title":"Stock Track | GENOR-B Soars 5.23% Intraday as Merger Completion and Renaming Take Effect","media":"Stock Track","content":"<p>GENOR-B (06998) surged 5.23% during the intraday session on Tuesday, reflecting strong investor optimism following the completion of its proposed merger and corporate renaming.</p><p>The company announced that all conditions for the merger have been fulfilled, with the completion taking effect at 9:00 a.m. (Hong Kong Time) on December 30, 2025. Concurrently, the company's name has been changed from \"Genor Biopharma Holdings Limited\" to \"Edding Genor Group Holdings Limited,\" signaling a new phase in its corporate identity.</p><p>Additionally, the company has appointed new directors, including Mr. Ni Xin and Ms. Zhai Jing as executive directors, and Dr. David Guowei Wang as a non-executive director, among others. These changes are expected to bring fresh leadership and strategic direction to the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GENOR-B Soars 5.23% Intraday as Merger Completion and Renaming Take Effect</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GENOR-B Soars 5.23% Intraday as Merger Completion and Renaming Take Effect\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-30 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENOR-B (06998) surged 5.23% during the intraday session on Tuesday, reflecting strong investor optimism following the completion of its proposed merger and corporate renaming.</p><p>The company announced that all conditions for the merger have been fulfilled, with the completion taking effect at 9:00 a.m. (Hong Kong Time) on December 30, 2025. Concurrently, the company's name has been changed from \"Genor Biopharma Holdings Limited\" to \"Edding Genor Group Holdings Limited,\" signaling a new phase in its corporate identity.</p><p>Additionally, the company has appointed new directors, including Mr. Ni Xin and Ms. Zhai Jing as executive directors, and Dr. David Guowei Wang as a non-executive director, among others. These changes are expected to bring fresh leadership and strategic direction to the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物","start_time":0,"source_url":"","article_id":"1159197708","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159197708","pubTimestamp":1767058385,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GENOR-B (06998) surged 5.23% during the intraday session on Tuesday, reflecting strong investor optimism following the completion of its proposed merger and corporate renaming.The company announced...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物"},"translate_title":"个股追踪|嘉和-B盘中大涨5.23%合并完成更名生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"GENOR-B (06998) surged 5.23% during the intraday session on Tuesday, reflecting strong investor optimism following the completion of its proposed merger and corporate renaming.The company announced that all conditions for the merger have been fulfilled, with the completion taking effect at 9:00 a.m. (Hong Kong Time) on December 30, 2025. Concurrently, the company's name has been changed from \"Genor Biopharma Holdings Limited\" to \"Edding Genor Group Holdings Limited,\" signaling a new phase in its corporate identity.Additionally, the company has appointed new directors, including Mr. Ni Xin and Ms. Zhai Jing as executive directors, and Dr. David Guowei Wang as a non-executive director, among others. These changes are expected to bring fresh leadership and strategic direction to the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159197708","isCrawlerRequest":true}